文献速递临床免疫质量管理与危急值

按ISO/TS 20914评估免疫比浊法检测11种血清蛋白的测量不确定度:一年实验室数据分析

Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis.
PubMed 文献 · Clin Chem Lab Med · 2025-08-21

本研究基于Roche Cobas分析仪一年室内质控数据,按ISO/TS 20914估算11种免疫比浊法检测血清蛋白的测量不确定度,并参照EFLM模型确定最大允许不确定度。仅IgA和RF分别在两个质控水平满足所需和最低MAU,CRP、铜蓝蛋白、转铁蛋白和β2-微球蛋白的MU超出靶值。

要点

  • 仅IgA在两个质控水平满足所需MAU,RF满足最低MAU。
  • CRP、铜蓝蛋白、转铁蛋白和β2-微球蛋白的MU在两个水平均超靶。
  • C3、C4、IgG和IgM在IQC1超最低MAU,IQC2可接受。

核心结论

  • 免疫比浊法检测血清蛋白长期保持可接受精密度仍是挑战,需方法学改进和更严格质量监测。

研究设计与样本

  • 利用Roche Cobas分析仪一年室内质控数据,按ISO/TS 20914估算11种血清蛋白的测量不确定度。
  • 假设外部质量评估数据偏差可忽略,按EFLM APS选择标准确定最大允许不确定度。

主要发现

  • IgA和RF是仅有的两个分别在两个质控水平满足所需和最低MAU的分析物。
  • CRP、铜蓝蛋白、转铁蛋白和β2-微球蛋白的MU在两个水平均超出靶值。
  • C3、C4、IgG和IgM的MU在IQC1超出最低MAU,在IQC2仍可接受。
  • ASO的MU计算为10.01%和7.22%,但因缺乏参考数据无法评估。

关键数值与推荐

  • IgA在两个质控水平满足所需MAU,RF在两个质控水平满足最低MAU。
  • CRP、铜蓝蛋白、转铁蛋白和β2-微球蛋白的MU在两个质控水平均超靶。
  • C3、C4、IgG和IgM的MU在IQC1超最低MAU,IQC2可接受。
  • ASO的MU为10.01%和7.22%,因缺乏参考数据无法评估。

临床怎么用

  • 应改进CRP、IgG、IgM、铜蓝蛋白、转铁蛋白和β2-微球蛋白的检测精密度。
  • 使用更新校准品可能有助于降低CRP的测量不确定度。
  • 建议对免疫比浊法血清蛋白开展测量不确定度评估并加强质量监测。

局限性

  • 假设外部质量评估数据偏差可忽略。
  • ASO因缺乏参考数据无法评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Measurement uncertainty (MU) plays an important role in the interpretation of laboratory results, but data on serum proteins analyzed by immunoturbidimetry according to ISO/TS 20914 are limited. METHODS: MU of 11 serum proteins, including CRP, RF, ASO, IgG, IgA, IgM, C3, C4, ceruloplasmin, transferrin, and β2-microglobulin, were estimated using 1-year internal quality control (IQC) data obtained from Roche Cobas analyzers. MU was calculated using uncertainty and calibrator uncertainty according to ISO/TS 20914, assuming negligible deviation from external quality assessment data. Analytical performance specification (APS) models were selected according to the EFLM APS selection criteria, and maximum allowable uncertainty (MAU) values were determined based on sources such as EFLM models and literature. RESULTS: IgA and RF were the only two analytes that met the required and minimum MAU values, respectively, at both IQC levels. MU values for CRP, ceruloplasmin, transferrin, and β2-microglobulin exceeded targets at both levels. MU for C3, C4, IgG, and IgM exceeded the minimum MAU at IQC1 but remained acceptable at IQC2. MU values for ASO were calculated as 10.01 and 7.22 % but could not be evaluated due to a lack of reference data. Assay precision should be improved for CRP, IgG, IgM, ceruloplasmin, transferrin, and β2-microglobulin. Use of updated calibration materials for CRP may help reduce MU. CONCLUSIONS: Maintaining acceptable precision over a long period remains a challenge for serum proteins analyzed by immunoturbidimetry, highlighting the need for methodological improvements and stricter quality monitoring. In this context, MU assessment is crucial.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Yurt EF, Alpdemir M, Şeneş M, et al. Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis. Clin Chem Lab Med. 2025. PMID: 40831382. doi:10.1515/cclm-2025-0654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。